Evidence-informed health policy 4 Case descriptions of organizations that support the use of research evidence

Implementation Science

Volumn 3, Issue 1, 2008, Pages

  Lavis, John N ^a,b   Moynihan, Ray ^c   Oxman, Andrew D ^d   Paulsen, Elizabeth J ^d  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY OF NEWCASTLE   (Australia)

^d NORWEGIAN KNOWLEDGE CENTRE FOR THE HEALTH SERVICES   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84921001484     PISSN: None     EISSN: 17485908     Source Type: Journal    
DOI: 10.1186/1748-5908-3-56     Document Type: Article

References (25)

1. Evidence-informed health policy 1 Synthesis of findings from a multi-method study of organizations that support the use of research evidence. JN Lavis AD Oxman R Moynihan EJ Paulsen, Implementation Science 2008 3 53 10.1186/1748-5908-3-53 19091107
2. Evidence-informed health policy 2 Survey of organizations that support the use of research evidence. JN Lavis EJ Paulsen AD Oxman R Moynihan, Implementation Science 2008 3 54 10.1186/1748-5908-3-54 19091108
3. Evidence-informed health policy 3 Interviews with the directors of organizations that support the use of research evidence. JN Lavis AD Oxman R Moynihan EJ Paulsen, Implementation Science 2008 3 55 10.1186/1748-5908-3-55 19091109
4. R Moynihan AD Oxman JN Lavis E Paulsen, Evidence-Informed Health Policy: Using Research to Make Health Systems Healthier Report from the Kunnskapssenteret (Norwegian Knowledge Centre for the Health Services), No. 1-2008 Oslo: Norwegian Knowledge Centre for the Health Services 2008
5. How do researchers influence decision-makers? Case studies of Mexican policies. J Trostle M Bronfman A Langer, Health Policy and Planning 1999 14 103 114 10.1093/heapol/14.2.103
6. Council on Health Research for Development (COHRED) Working Group on Research to Action and Policy, Lessons in Research to Action and Policy: Case Studies from Seven Countries Geneva: Council on Health Research and Development 2000
7. Examining the role of health services research in public policymaking. JN Lavis SE Ross JE Hurley JM Hohenadel GL Stoddart CA Woodward J Abelson, Milbank Quarterly 2002 80 125 154 10.1111/1468-0009.00005 11933791
8. Translating research into policy and practice in developing countries: A case study of magnesium sulphate for pre-eclampsia. M Aaserud S Lewin S Innvaer EJ Paulsen AT Dahlgren M Trommald L Duley M Zwarenstein AD Oxman, BMC Health Services Research 2005 5 16262902
9. System and market failures: The unavailability of magnesium sulphate for the treatment of eclampsia and pre-eclampsia in Mozambique and Zimbabwe. E Sevene S Lewin A Mariano G Woelk AD Oxman S Matinhure J Cliff B Fernandes K Daniels, British Medical Journal 2005 331 765 769 16195297 10.1136/bmj.331.7519. 765
10. Decision-makers and the usefulness of research evidence in policy implementation: A case study from Lao PDR. G Tomson C Paphassarang K Jonsson K Houamboun K Akkhavong R Wahlstrom, Social Science & Medicine 2005 61 1291 1299 10.1016/j.socscimed.2005.01.014
11. Factors influencing the utilization of research findings by heal policy-makers in a developing country: The selection of Mali's essential medicines. MA Albert A Fretheim D Maiga, Health Research Policy and Systems 2007 5 10.1186/1478-4505-5-2
12. Health technology assessment in its local contexts: Studies of telehealthcare. C May M Mort T Williams F Mair L Gask, Social Science and Medicine 2003 57 697 710 10.1016/S0277-9536(02)00419-7
13. Differences between systematic reviews and health technology assessments: A trade-off between the ideals of scientific rigor and the realities of policy making. D Rotstein A Laupacis, International Journal of Technology Assessment in Health Care 2004 20 177 183 10.1017/S0266462304000959 15209177
14. Joint project of the international network of agencies for health technology assessment Part 1: Survey results on diffusion, assessment, and clinical use of positron emission tomography. J Hastings EJ Adams, International Journal of Technology Assessment in Health Care 2006 22 143 148 10.1017/S026646230605094X 16571188
15. Health technology assessment in Germany. Status, challenges, and development. M Perleth R Busse, International Journal of Technology Assessment in Health Care 2000 16 412 428 10.1017/S0266462300101072 10932416
16. Devolving healthcare delivery to regional health authorities: Is health technology assessment prepared to follow? BR Gibis D Juzwishin, Healthcare Management Forum 2003 16 24 31 12908163
17. S Hill S Garattini J van Loenhout B O'Brien K de Joncheere, Technology Appraisal Programme of the National Institute for Clinical Excellence: A Review by WHO Geneva: World Health Organization 2003
18. J Eskola K Hockerstedt H Makarainen A Oxman N Rehnqvist K Lampe, The Future of FinOHTA: An External Review Helsinki: Stakes 23 2004
19. K Joncheere S Hill N Klazinga M Makela AD Oxman, The Clinical Guideline Programme of the National Institute for Health and Clinical Excellence: A Review by WHO Geneva: World Health Organization 2006
20. Health policy-makers' perceptions of their use of evidence: A systematic review. S Innvaer G Vist M Trommald AD Oxman, Journal of Health Services Research and Policy 2002 7 239 244 10.1258/135581902320432778
21. Towards systematic reviews that inform health care management and policy-making. JN Lavis HTO Davies AD Oxman J-L Denis K Golden-Biddle E Ferlie, Journal of Health Services Research and Policy 2005 10 S1:35 S1:48 10.1258/1355819054308549
22. Improving the use of research evidence in guideline development: 4. Managing conflicts of interests. EA Boyd LA Bero, Health Res Policy Syst 2006 4 16 17140441 10.1186/1478-4505-4-16
23. Improving the use of research evidence in guideline development: 8. Synthesis and presentation of evidence. AD Oxman HJ Schunemann A Fretheim, Health Res Policy Syst 2006 4 20 17147809 10.1186/1478-4505-4-20
24. EVIPNet: Translating the spirit of Mexico. M Hamid T Bustamante-Manaog TV Dung K Akkhavong H Fu Y Ma X Zhong R Salmela U Panisset T Pang, Lancet 2005 366 1758 1760 10.1016/S0140-6736(05)67709-4 16298204
25. Use of evidence in WHO recommendations. AD Oxman JN Lavis A Fretheim, Lancet 2007 369 1883 1889 10.1016/S0140-6736(07)60675-8 17493676